A2 Refereed review article in a scientific journal

Aivojen magneettikuvaus MS-taudin immunologisen hoidon seurannassa




AuthorsElovaara I, Soilu-Hänninen M, Kuusisto H, Martola J, Tienari P, Färkkilä M, Remes AM

Publication year2015

JournalDuodecim

Volume131

Issue17

First page 1571

Last page1580


Abstract

Magnetic resonance imaging of the brain is currently the most sensitive method in detecting the lesions caused by multiple sclerosis. Assessment of the immunological treatment response used in the treatment of multiple sclerosis should be based on the clinical picture and brain MRI. T2-, flair- and T1-biased images, gadolinium enhancement and assessment of atrophy are required for MRI monitoring. In the first-line immune therapy MRI is taken at 6 to 12 months after starting the drug therapy, in fingolimod therapy after 6 to 12 months and 1 to 2 years, respectively, and in alemtuzumab and natalizumab therapy after one and two years




Last updated on 2024-26-11 at 15:10